J0275 Alprostadil urethral supposAlprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Status E: excluded from the PFS by regulation.
1 of 1 payer prior-auth lists that name J0275 require prior authorization or set conditions: UnitedHealthcare Community Plan.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| UnitedHealthcare Community Plan | UnitedHealthcare Community Plan of New York | NY | prior auth required | Oct 1, 2026 | Prior authorization requirements for UnitedHealthcare Community Plan of New York Effective October 1, 2026 |
J0275 appears in 2 coverage policies from Aetna, Centene.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Erectile Dysfunction and Peyronie's Disease (0007) | covered if criteria are met | Jul 29, 2026 | payer document |
| Centene | Alprostadil (Caverject, Edex, Muse) (CP.CPA.02) | covered if criteria are met | Aug 1, 2026 | payer document |
Prior authorization required or conditional in IN, NY.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.